Rational advice on how to handle downturns. A biotech developing synthetic CBD treatments with 245% upside. And a utility stock breaking out to an all-time high.

Also inside: Relax, take the long view, and get off your phone. Plus: This gas purification company has a record backlog and a projected return of nearly 130%.

Today’s Digest will feature clear-eyed investment advice, a stock investors are flocking to, and a biotech working on CBD treatments with huge upside.

Cronos Group CEO Michael Gorenstein gave us his prognostication on consolidation in the cannabis sector earlier this year. Cronos shares are nearly 40% higher since.

Capital Ideas contributor Fabrice Taylor dissected Aphria’s trading in June of 2017. See Taylor’s analysis of Aphria’s activities and the response of company CEO Vic Neufeld.

Hear about the strategy shift Peekaboo Beans has implemented to “supercharge” growth. And look out for an interview with the CEO of a cannabis company building a global footprint.

Coverage of a stock that could add to its 1,000% gain. The new Digest on a company with takeout potential. Watch the replay of our live interview with Kintavar’s CEO.

Also inside: Led by former exec of Victoria’s Secret, this U.S. cannabis retail player could gain 60%. Plus: A gold stock that could double; And a long-time winner flashing a technical buy.